Images of Spine CareDestructive Mycobacterium simiae infection of the lumbar spine and retroperitoneum in an immunocompetent adult
References (5)
- et al.
Disseminated disease caused by Mycobacterium simiae in AIDS patients: a report of three cases
Clin Microbiol Infect
(2010) - et al.
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease
Int J Antimicrob Agents
(2012)
There are more references available in the full text version of this article.
Cited by (5)
Infections due to Mycobacterium simiae
2015, Enfermedades Infecciosas y Microbiologia ClinicaInvestigation of drug regimens and treatment outcome in patients with Mycobacterium Simiae: a systematic review
2022, Expert Review of Anti-Infective TherapyNon tuberculous mycobacteria related spondylodiscitis: A case report and systematic literature review
2020, Infezioni in MedicinaNoncontiguous genome sequence of Mycobacterium simiae strain DSM 44165<sup>T</sup>
2013, Standards in Genomic Sciences
FDA device/drug status: Approved (ciprofloxacin, clarithromycin, and ethambutol).
Author disclosures: VB: Nothing to disclose. JGS: Nothing to disclose.
Published by Elsevier Inc.